Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice [Corrigendum]

Niu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560. The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows. Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, S...

Full description

Bibliographic Details
Main Authors: Niu S, Ren Q, Chen S, Pan X, Yue L, Chen X, Li Z, Zhen R
Format: Article
Language:English
Published: Dove Medical Press 2023-09-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
nafld
empagliflozin
metabolomics
differentially expressed metabolites
obesity
Online Access:https://www.dovepress.com/corrigendum-metabolic-and-hepatic-effects-of-empagliflozin-on-nonalcoh-peer-reviewed-fulltext-article-DMSO
Description
Summary:Niu S, Ren Q, Chen S, et al. Diabetes Metab Syndr Obes. 2023;16:2549–2560. The authors have advised the correspondence section on page 2549 is incorrect. The correct correspondence details are as follows. Correspondence: Shuchun Chen, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People’s Republic of China, Email chenshuc2014@163.com The authors apologize for this error.
ISSN:1178-7007

Similar Items